Literature DB >> 12602118

Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells.

Claudia Weidekamm1, Peter Hauser, Cornelia Hansmann, Christoph Schwarz, Hans Klingler, Gert Mayer, Rainer Oberbauer.   

Abstract

BACKGROUND: Tubular atrophy is a common histological feature of chronic renal failure, and epithelial cell death by apoptosis might play an important role in its pathogenesis. Angiotensin II contributes to the progressive nature of many kidney diseases and treatment with angiotensin converting enzyme inhibitors preserves the structure of the tubulointerstitial compartment in human and experimental renal diseases.
METHODS: Primary cultures of human renal proximal tubular epithelial cells were co-incubated with angiotensin II alone or in combination with the angiotensin II AT1 receptor antagonist losartan or/and the AT2 antagonist PD123319. Apoptosis was determined after 20 hours by TUNEL staining and flow cytometry.
RESULTS: Angiotensin II at concentrations of 10(-9) M induced apoptosis (control vs. angiotensin II 4 +/- 3% vs. 73 +/- 11%; p < 0.05). This effect was completely offset by co-incubation with the angiotensin II AT2 receptor blocker at concentrations 10(-7) M (control vs. PD123319 4 +/- 3% vs. 8 +/- 3%; p < 0.05); AT1 blockade was ineffective in apoptosis inhibition. When both angiotensin receptors were blocked, no additional effect on apoptosis inhibition could be detected.
CONCLUSION: We provided evidence, that physiological concentrations of angiotensin II can induce apoptosis of human renal proximal tubule epithelial cells. This effect is mediated via AT2 receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12602118

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  6 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells.

Authors:  Min Liu; Danqing Jing; Yan Wang; Yu Liu; Shinan Yin
Journal:  Mol Cell Biochem       Date:  2014-11-28       Impact factor: 3.396

3.  Effects of adaptive exercise on apoptosis in cells of rat renal tubuli.

Authors:  Marzena Podhorska-Okolow; Piotr Dziegiel; Eugenia Murawska-Cialowicz; Jolanta Saczko; Julita Kulbacka; Agnieszka Gomulkiewicz; Katia Rossini; Zbigniew Jethon; Ugo Carraro; Maciej Zabel
Journal:  Eur J Appl Physiol       Date:  2006-11-11       Impact factor: 3.078

4.  Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC).

Authors:  Ana Konvalinka; Joyce Zhou; Apostolos Dimitromanolakis; Andrei P Drabovich; Fei Fang; Susan Gurley; Thomas Coffman; Rohan John; Shao-Ling Zhang; Eleftherios P Diamandis; James W Scholey
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

5.  Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment.

Authors:  Matheus Correa-Costa; Hátylas Azevedo; Mariane Tami Amano; Giselle Martins Gonçalves; Meire Ioshie Hyane; Marcos Antonio Cenedeze; Paulo Guilherme Renesto; Alvaro Pacheco-Silva; Carlos Alberto Moreira-Filho; Niels Olsen Saraiva Câmara
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  Influence of Angiotensin II on cell viability and apoptosis in rat renal proximal tubular epithelial cells in in vitro studies.

Authors:  Aleksandra Piotrowska; Magdalena Chmielewska; Waldemar Andrzejewski; Piotr Dziegiel; Marzenna Podhorska-Okolow
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Jul-Sep       Impact factor: 1.636

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.